Skip to main content
Premium Trial:

Request an Annual Quote

ZyGem, Morpho Ink Forensics Alliance

NEW YORK (GenomeWeb News) – ZyGem today said it has signed an agreement under which Morpho will market the firm's sample preparation and forensics analysis products to police forces worldwide.

The deal with Morpho, a subsidiary of the Safran Group that sells identity management and security control products, includes a strategic research and development collaboration. Financial and other terms of the agreement were not disclosed.

The collaboration builds on a separate collaboration between ZyGem and Lockheed Martin to develop an integrated sample-to-answer system aimed at the forensics market.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.